“Bayer initiated the recall after identifying that the labeling on the foil blister card of certain packages within the lot (less than 4 percent) were printed with the label reversed,” according to an article on Pharmaceutical Online.
The big problem is this is a combo pack of both day and night liquid gels, and the label for each was incorrectly positioned on the other. So conceivably, a consumer could take the night-time dose which contains antihistamine, thinking they were taking the daytime dose which does not contain antihistamine, and suffer an adverse reaction to antihistamine. Bayer initiated the recall after consumers reported problems.
What I find fascinating is from all the packaging lines I have seen, and all the controls and redundant features (sensors, imaging systems, etc.) that are put in place, I cannot imagine an error like this getting past quality control.
Of course, we will probably never know what happened, but what I wouldn’t give to be a fly on the wall. Not blaming Bayer--Murphy’s Law, I guess?
Get your daily dose of global packaging trends, follow me on Twitter.
The big problem is this is a combo pack of both day and night liquid gels, and the label for each was incorrectly positioned on the other. So conceivably, a consumer could take the night-time dose which contains antihistamine, thinking they were taking the daytime dose which does not contain antihistamine, and suffer an adverse reaction to antihistamine. Bayer initiated the recall after consumers reported problems.
What I find fascinating is from all the packaging lines I have seen, and all the controls and redundant features (sensors, imaging systems, etc.) that are put in place, I cannot imagine an error like this getting past quality control.
Of course, we will probably never know what happened, but what I wouldn’t give to be a fly on the wall. Not blaming Bayer--Murphy’s Law, I guess?
Get your daily dose of global packaging trends, follow me on Twitter.
